What Is the IEV ETF? A Complete Guide to Returns, Expense Ratio, Holdings, and Alternative ETFs
A flagship ETF that invests in 350 large-cap stocks across developed European markets, offering an efficient way to track the performance of the broader European economy.
What Is This ETF?
The fund replicates the S&P Europe 350 Index, holding leading companies from 16 developed European countries on a market-cap-weighted basis. It provides comprehensive exposure by including not only eurozone countries but also major non-eurozone markets such as the United Kingdom and Switzerland.
Rather than focusing on individual countries, it offers broad exposure to the European market as a whole, making it well suited to long-term investors seeking geographic diversification.
Launched by iShares in 2000, it is a passively managed ETF that tracks an index.
How Does It Invest?
| Item | Details |
|---|---|
| Tracking Index | S&P Europe 350 Index |
| Management Style | Passive (index tracking) |
| Rebalancing Frequency | Quarterly |
| Dividend Frequency | Semiannual |
| Expense Ratio | 0.60% |
The portfolio is built around high-quality large-cap stocks in Europe's health care, financial, and consumer goods sectors. By diversifying across 350 holdings, it lowers single-company risk while pursuing the long-term growth value of the European economy.
- Comprehensive exposure to developed European markets, including the UK and Switzerland
- Proven stability backed by more than 20 years of operating history
- High liquidity and credibility from a focus on European large caps
Size and Costs
Assets under management (AUM) stand at $1.6B, and the expense ratio is 0.60% per year.
It has been managed for a long time as a core European market holding, and compared with similar low-cost ETFs, it maintains a steady position in terms of track record and market representation.
Performance and Trends
Return trends are shaped by earnings improvements at European companies and shifts in monetary policy, and the fund tends to be sensitive to the global business cycle and currency fluctuations.
From a global asset allocation perspective, inflows stand out when demand emerges for developed markets outside the US, and changes in the political and economic environment of major European countries act as key variables.
Strengths and Weaknesses
Broad exposure to developed European markets is its strength, but a higher expense ratio than competing products and currency volatility are factors to consider.
💪 Key Strengths
⚠️ Points to Watch
Alternative ETFs and Related Products
The VEA, IEFA, and VXUS shown in the table are broad ETFs covering developed markets worldwide, including Europe, whereas IEV concentrates only on the European region. If cost efficiency is a priority, VGK or IEUR can be alternatives that invest in Europe at a lower expense ratio, and if you want to focus only on eurozone countries, it is worth considering EZU or FEZ as well. You can also build a portfolio by comparing it with an approach that concentrates on individual countries such as the United Kingdom (EWU).
| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
| Vanguard FTSE Developed Markets ETF | $69.44 | -1.5% | $231.7B | 0.03% | 2.45% | +13.8% | |
| iShares Core MSCI EAFE ETF | $96.31 | -0.9% | $191.0B | 0.07% | 3.42% | +9.1% | |
| Vanguard Total International Stock ETF | $82.37 | -1.5% | $163.0B | 0.05% | 2.41% | +10.1% | |
| Vanguard Total World Stock ETF | $155.33 | -1.7% | $84.2B | 0.06% | 1.55% | +10.7% | |
| iShares MSCI EAFE ETF | $103.37 | -0.9% | $77.3B | 0.32% | 3.25% | +9.2% |
| Ticker | Name | Weight | Price | Change | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|---|
| ASML | ASML Holding NV | 0.09% | $1565.90 | -6.5% | $603.5B | 38.6 | 0.66% |
| AZN | Astrazeneca plc | 0.04% | $186.65 | +7.0% | $289.5B | 27.9 | 1.79% |
| HSBC | HSBC Holdings plc ADR | 0.04% | $85.42 | -1.4% | $292.7B | 11.2 | 4.86% |
| NVS | Novartis AG ADR | 0.04% | $160.79 | -0.2% | $294.3B | 30.7 | 2.7% |
| Shell plc ADRhedged | 0.02% | $78.75 | +0.7% | $0.0M | - | 1.55% | |
| SHEL | Shell Plc ADR | 0.02% | $108.69 | +0.9% | $308.8B | 9.4 | 2.9% |
Investor Checkpoints
These are the key checkpoints to review before investing in IEV. Weigh the geopolitical risks specific to the European market and the cost structure together before deciding whether to add it to your portfolio.
| Checkpoint | What to Check | Current Status |
|---|---|---|
| 💵 Expense Ratio | Review the cost difference versus similar low-cost ETFs | Somewhat high |
| 💱 Currency Impact | Trends in the value of the euro and the pound | Needs review |
| 📊 Regional Weights | Check changes in the weights of the UK and other major countries | Stable |
| 🏢 Sector Concentration | Whether the fund is skewed toward health care and financials | Focused on quality stocks |
In the European market, policy changes in individual countries and currency fluctuations have a major impact on returns, so you should closely watch the overall macro environment and the flow of geopolitical news.
This product suits investors who want standard exposure to large-cap stocks in developed Europe. However, cost-sensitive investors should also compare lower-cost alternatives that track the same region.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.